Chinese medicine · Bencao tradition; Sun Simiao; modern pharmacovigilance

Respect the toxicity of medicines; do not take strong drugs lightly

Shennong Bencao Jing 序錄 (下藥…多毒,不可久服); Beiji qianjin yaofang juan 26 (藥性剛烈,猶若御兵)

What the tradition teaches

What the tradition teaches

Lower drugs are “mostly toxic and not to be taken long” [1]. Sun Simiao warned that the nature of drugs is fierce, “like commanding soldiers”: used wrongly, they injure many [2].

Historical context

What the tradition teaches

Classical authors knew that strong drugs could harm and graded them accordingly. Modern hazards add new layers: substitution of one plant for another, contamination, adulteration with prescription drugs, and interactions with modern medicines [3].

Original meaning and purpose

What the tradition teaches

Healing power and harming power come together; the physician and the seller bear responsibility for accuracy and restraint.

How Eternal Light interprets it

How Eternal Light interprets it

Eternal Light reads this teaching as being about honesty and care in the chain that connects grower, seller, prescriber and patient. A mislabelled product, a substituted plant or an undeclared drug is a loss of light at every link — most of all for the patient who trusted it. The framework holds that a tradition increases its light by facing its harms openly.

Observable mechanism

What research supports

Herbal products containing aristolochic acid cause progressive kidney fibrosis and urothelial cancer; some Asian herbal products contain toxic heavy metals or undeclared drugs; some herbs interact with prescription medicines.

What the research shows

What research supports

Strong for harm. In Belgium, women on a slimming regimen in which Stephania tetrandra had been replaced by Aristolochia fangchi developed rapidly progressive interstitial renal fibrosis [4]; among 39 such patients examined after end-stage disease, 18 (46%) had urothelial carcinoma, all tissues contained aristolochic-acid DNA adducts, and cumulative dose predicted risk [5]. Molecular epidemiology links aristolochia remedies to Taiwan's very high rates of upper-tract urothelial cancer [6]. Reviews document heavy metals and undeclared drugs in Asian herbal medicines, though prevalence is uncertain [7]; DNA sequencing of 15 TCM products detected potentially toxic Ephedra and Asarum and DNA of endangered Asiatic black bear and saiga antelope, mostly undeclared [8]. Clinical trials and case reports document herb–drug interactions; ginseng, for example, may interact with warfarin and phenelzine [9].

Exceptions, conflicts, and open questions

Most herbal products are not contaminated, and many are sold under quality controls; the risk depends heavily on source and regulation. Individual-level risk from any one product is often unknown.

Who gains or loses light

How Eternal Light interprets it

Eternal Light’s reading (a metaphysical interpretation, not an observed measurement)
ParticipantEffectWhy
The actor (self) lossKidney failure and cancer from aristolochic acid; heavy-metal exposure
Another person lossTrust broken between seller, prescriber and patient
Animals lossUndeclared endangered species in products
Community gainWhen regulation and testing respond, everyone is safer

Sources cited

  1. Attributed to Shennong; anonymous Eastern Han compilers; later reconstructions. 神農本草經 (Shennong Bencao Jing, Divine Farmer's Materia Medica), Wikisource Chinese edition (c. 1st–2nd c. CE)
  2. Sun Simiao (孫思邈). 備急千金要方 (Beiji qianjin yaofang), juan 26 食治 (Dietary Therapy), Wikisource (c. 652 CE)
  3. National Center for Complementary and Integrative Health (NIH). Traditional Chinese Medicine: What You Need To Know (2019 (last updated April 2019))
  4. Vanherweghem JL, Depierreux M, Tielemans C, et al.. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs (1993)
  5. Nortier JL, Martinez MC, Schmeiser HH, et al.. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) (2000)
  6. Chen CH, Dickman KG, Moriya M, et al.; Grollman AP. Aristolochic acid-associated urothelial cancer in Taiwan (2012)
  7. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines (2002)
  8. Coghlan ML, Haile J, Houston J, Murray DC, White NE, Moolhuijzen P, Bellgard MI, Bunce M. Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns (2012)
  9. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review (2009)

Related teachings